Clinical trial transparency rising, study for industry finds

Disclosure of clinical trial results for medicines approved for use in the EU reached an all-time high in 2014, a study for the Association of the British Pharmaceutical Industry has found.

Of 542 clinical trials for the 32 medicines approved by the European Medicines Agency in 2014, 93 per cent disclosed their results within a year, the ABPI reported on 19 December. By the time the association’s study ended in July 2016, 96 per cent of the trials had disclosed their results.

The study was the final one in a series that has examined disclosure rates for industry-sponsored clinical trials between 2009 and 2014. Disclosure rates rose from 71 per cent in 2009 to 93 per cent in 2014, the ABPI said.